Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 44, Pages 6097-6108
Publisher
Springer Nature
Online
2017-07-03
DOI
10.1038/onc.2017.214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma
- (2016) Lili Bao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2)
- (2016) Peter J. Noy et al. FASEB JOURNAL
- Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival
- (2015) Elise Langenkamp et al. CANCER RESEARCH
- CD93 gene polymorphism is associated with disseminated colorectal cancer
- (2015) Renate S. Olsen et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- The I-TASSER Suite: protein structure and function prediction
- (2015) Jianyi Yang et al. NATURE METHODS
- Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth
- (2015) P J Noy et al. ONCOGENE
- MULTIMERIN2 binds VEGF-A primarily via the carbohydrate chains exerting an angiostatic function and impairing tumor growth
- (2015) Roberta Colladel et al. Oncotarget
- A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors
- (2014) L. A. Diaz et al. CLINICAL CANCER RESEARCH
- RhoJ interacts with the GIT-PIX complex and regulates focal adhesion disassembly
- (2014) E. Wilson et al. JOURNAL OF CELL SCIENCE
- A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis
- (2013) Massimo Masiero et al. CANCER CELL
- SILAC-Based Proteomics of Human Primary Endothelial Cell Morphogenesis Unveils Tumor Angiogenic Markers
- (2013) Sara Zanivan et al. MOLECULAR & CELLULAR PROTEOMICS
- Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro
- (2013) M K Ki et al. ONCOGENE
- The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice
- (2012) Amy J. Naylor et al. ARTHRITIS AND RHEUMATISM
- Pericytes promote selective vessel regression to regulate vascular patterning
- (2012) N. Simonavicius et al. BLOOD
- MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway
- (2011) E Lorenzon et al. ONCOGENE
- Identification and angiogenic role of the novel tumor endothelial marker CLEC14A
- (2011) M Mura et al. ONCOGENE
- RhoJ/TCL Regulates Endothelial Motility and Tube Formation and Modulates Actomyosin Contractility and Focal Adhesion Numbers
- (2010) Sukhbir Kaur et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion
- (2010) Seung-Sik Rho et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma
- (2008) Nicole Simonavicius et al. MODERN PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started